2-Chlorocyclohepta-2,4,6-trienone

Catalog No. :
ACQKWA245
CAS No. :
3839-48-3
Molecular Formula :
C7H5ClO
Molecular Weight :
140.57

IUPAC Name:2-chlorocyclohepta-2,4,6-trien-1-one

2-Chlorocyclohepta-2,4,6-trienone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$77.00Login to see priceIn stockIn stock
5g98%$317.00Login to see priceIn stockIn stock
25g98%$1364.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chlorocyclohepta-2,4,6-trienone
IUPAC Name2-chlorocyclohepta-2,4,6-trien-1-one
MDL No.MFCD00182497
Molecular FormulaC7H5ClO
Molecular Weight140.57
SMILESO=C1C(Cl)=CC=CC=C1
InChI KeyMTHNMAUDCHXFMM-UHFFFAOYSA-N
SynonymDTXSID90191734 | NSC328816 | NSC-328816 | 4-07-00-00502 (Beilstein Handbook Reference) | 7Y65UFZ23T | 9-AMINO-1,2,3,4-TETRAHYDROACRIDINEHCLHYDRATE | MFCD00182497 | 2,4,6-CYCLOHEPTATRIEN-1-ONE, 2-CHLORO- | 2-Chlortropon | MTHNMAUDCHXFMM-UHFFFAOYSA-N | 2,6-
CAS No.3839-48-3
PubChem CID19691

Safety Data

Pictogram
CorrosiveHarmful or irritantHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H314-H317-H334
Precautionary Statement(s)
P261-P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACQKWA245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKXOV765 route compound structure diagram
    ACKXOV765533-75-5 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACQKWA245 route product structure diagram
    ACQKWA2453839-48-3 In Stock
Inquiry

2. ACQKWA245 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQKWA245 route product structure diagram
    ACQKWA2453839-48-3 In Stock
Inquiry

Comments (0)